close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,041.1

+2.25%↑

JNJ

247.68

+1.83%↑

ABBV

230.26

+2.11%↑

NVS

169.04

+1.88%↑

MRK

123.57

+3.19%↑

LLY

1,041.1

+2.25%↑

JNJ

247.68

+1.83%↑

ABBV

230.26

+2.11%↑

NVS

169.04

+1.88%↑

MRK

123.57

+3.19%↑

LLY

1,041.1

+2.25%↑

JNJ

247.68

+1.83%↑

ABBV

230.26

+2.11%↑

NVS

169.04

+1.88%↑

MRK

123.57

+3.19%↑

LLY

1,041.1

+2.25%↑

JNJ

247.68

+1.83%↑

ABBV

230.26

+2.11%↑

NVS

169.04

+1.88%↑

MRK

123.57

+3.19%↑

LLY

1,041.1

+2.25%↑

JNJ

247.68

+1.83%↑

ABBV

230.26

+2.11%↑

NVS

169.04

+1.88%↑

MRK

123.57

+3.19%↑

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorGezondheidszorg

29.32 -0.51

Strong Buy

Prijsupdate 27 feb 2026, 20:53 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

28.15

Max

29.49

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+44.71% upside

Dividenden

By Dow Jones

Volgende Winsten

5 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

524M

2.7B

Vorige openingsprijs

29.83

Vorige sluitingsprijs

29.32

Nieuwssentiment

By Acuity

33%

67%

93 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 feb 2026, 22:04 UTC

Winsten

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

DJ

Lezen

26 feb 2026, 23:55 UTC

Marktinformatie

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

DJ

Lezen

26 feb 2026, 23:40 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

DJ

Lezen

26 feb 2026, 23:37 UTC

Marktinformatie

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

DJ

Lezen

26 feb 2026, 23:32 UTC

Winsten

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

DJ

Lezen

26 feb 2026, 23:19 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

DJ

Lezen

26 feb 2026, 23:18 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

DJ

Lezen

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

DJ

Lezen

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Netflix Gives Up in Bidding War Over Warner -- Market Talk

DJ

Lezen

26 feb 2026, 23:01 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

DJ

Lezen

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

DJ

Lezen

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

DJ

Lezen

26 feb 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

DJ

Lezen

26 feb 2026, 22:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

26 feb 2026, 22:43 UTC

Marktinformatie

RBA Hike In March Is Being Underpriced -- Market Talk

DJ

Lezen

26 feb 2026, 22:33 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

DJ

Lezen

26 feb 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

DJ

Lezen

26 feb 2026, 22:13 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Bidding War Over Warner Bros. Set to Continue -- Market Talk

DJ

Lezen

26 feb 2026, 21:59 UTC

Winsten

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

DJ

Lezen

26 feb 2026, 21:58 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

DJ

Lezen

26 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

26 feb 2026, 21:49 UTC

Winsten

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

DJ

Lezen

26 feb 2026, 21:45 UTC

Winsten

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

DJ

Lezen

26 feb 2026, 21:44 UTC

Winsten

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

DJ

Lezen

26 feb 2026, 21:44 UTC

Winsten

Coles Expects Market to Remain Highly Competitive

DJ

Lezen

26 feb 2026, 21:44 UTC

Winsten

Coles Says Supermarket Customers Remain Value Oriented

DJ

Lezen

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

DJ

Lezen

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

DJ

Lezen

26 feb 2026, 21:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

DJ

Lezen

26 feb 2026, 21:41 UTC

Winsten
Acquisities, Fusies, Overnames

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

44.71% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 41.88 USD  44.71%

Hoogste 50 USD

Laagste 29 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

93 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,041.1

↑ +2.25%

JNJ

Johnson and Johnson

247.68

↑ +1.83%

ABBV

AbbVie Inc

230.26

↑ +2.11%

NVS

Novartis AG

169.04

↑ +1.88%

MRK

Merck & Co Inc.

123.57

↑ +3.19%
help-icon Live chat